|
Market Closed -
Bombay S.E.
05:00:48 2026-01-12 EST
|
5-day change
|
1st Jan Change
|
|
315.65 INR
|
-1.33%
|
 |
-4.91%
|
-6.27%
|
|
11-17 |
Gufic Biosciences Limited, Q2 2026 Earnings Call, Nov 17, 2025
| | |
11-14 |
Gufic Biosciences posts Sept-quarter consol revenue from operations 2.37 billion rupees
|
RE
| |
11-14 |
Gufic Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
|
CI
| |
25-09-30 |
Gufic Biosciences Limited Approves Final Dividend for the Financial Year Ended March 31, 2025
|
CI
| |
25-09-21 |
Ex-dividend day for final dividend
|
FA
| |
25-08-24 |
Gufic Ireland Limited announced that it has received ?0.001 million in funding from Gufic Biosciences Limited
|
CI
| |
25-08-14 |
Gufic Biosciences Limited, Q1 2026 Earnings Call, Aug 14, 2025
| | |
25-08-13 |
Gufic Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
|
CI
| |
25-06-02 |
Gufic Biosciences Limited, Q4 2025 Earnings Call, Jun 02, 2025
| | |
25-05-30 |
Gufic Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
|
CI
| |
25-05-30 |
Gufic Biosciences Limited Announces Additional Investment in Making Wholly Owned Subsidiary
|
CI
| |
25-05-30 |
Gufic Biosciences Limited announces Annual dividend, payable on October 29, 2025
|
CI
| |
25-04-15 |
Gufic Biosciences Appeals Tax Assessment Order
|
MT
| |
25-03-19 |
Gufic Biosciences Limited Receives Order from the Assessment Unit, Income Tax Department for Assessment Year 2023-24
|
CI
| |
25-02-17 |
Gufic Biosciences Limited, Q3 2025 Earnings Call, Feb 17, 2025
| | |
25-02-14 |
Gufic Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
|
CI
| |
25-02-07 |
Gufic Biosciences Limited Approves the Appointment of Akshya Kumar Mahapatra as an Independent Director
|
CI
| |
25-02-03 |
Gufic Biosciences Limited Appoints Rajeev Agarwal as the President Ferticare
|
CI
| |
25-01-14 |
Gufic Biosciences Makes Veira Life FZE a Wholly Owned Subsidiary
|
MT
| |
24-11-22 |
Gufic Biosciences Limited Announces Cessation of Gopal Madhavbhai Daptari as Independent Director
|
CI
| |
24-11-18 |
Gufic Biosciences Limited, Q2 2025 Earnings Call, Nov 18, 2024
| | |
24-11-14 |
Gufic Biosciences Limited Approves Reconstitution of Audit Committee (AC), Nomination & Remuneration Committee, Corporate Social Responsibility Committee and Risk Management Committee
|
CI
| |
24-11-14 |
Gufic Biosciences Limited Announces Reconstitution of Key Committees Following the Term Expiry of Gopal Daptari, Independent Director
|
CI
| |
24-11-14 |
Gufic Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
|
CI
| |
24-09-25 |
Gufic Biosciences Limited Approves Final Dividend for the Financial Year Ended March 31, 2024
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
